Overview
Sponsor-declared trial summary
Phase
Human pharmacology (Phase I) - Other
Status
Ended
Participants planned
20
Countries
1
Sites
1
Atopic dermatitis (AD)
Key facts
- Sponsor
- Sitryx Therapeutics Limited
- Participant type
- Healthy volunteers
- Age range
- 18-64 years
- Gender
- Male and Female
- Therapeutic area
- Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Trial duration
- 19 Nov 2025 → 20 Mar 2026
- Decision date (initial)
- 2025-11-14
- Transition trial
- No
- Low-intervention
- No
- Rare-disease indication
- No
- Vulnerable population
- No
Trial design
CTIS Part I — objectives, methods, condition coding
Conditions and MedDRA coding
Atopic dermatitis (AD)
Sponsors and contacts
Sponsor organisations, regulatory contacts, third parties
Sitryx Therapeutics Limited
- Sponsor organisation
- Sitryx Therapeutics Limited
- Address
- 101 Bellhouse Building, Magdalen Centre, The Oxford Science Park Magdalen Centre The Oxford Science Park
- City
- Oxford
- Postcode
- OX4 4GA
- Country
- United Kingdom
Scientific contact point
- Organisation
- Sitryx Therapeutics Limited
- Contact name
- Niamh Richmond
Public contact point
- Organisation
- Sitryx Therapeutics Limited
- Contact name
- Niamh Richmond
Locations
1 EU/EEA country · 1 investigational sites
By country
| Country | MS status | Planned subjects | Sites |
|---|---|---|---|
| Netherlands | Ended | 20 | 1 |
| Rest of world | — | 0 | — |
Investigational sites
Centre for Human Drug Research
Dermatology, Zernikedreef 8, 2333 CL, Leiden
Country notifications
Trial-start, recruitment-start, end and early-termination notifications submitted per Member State
| Country | Trial start | Trial end | Recruitment start | Recruitment end | Early termination |
|---|---|---|---|---|---|
| Netherlands | 2025-11-19 | 2026-03-20 | 2025-11-25 | 2026-01-06 |
Application history
1 submissions — initial application plus substantial / non-substantial modifications
| # | Type | Code | Submitted | Reference MS | Conclusion | Decision date |
|---|---|---|---|---|---|---|
| 1 | INITIAL | IN | 2025-09-15 | Netherlands | Acceptable 2025-11-14
|
2025-11-14 |